13F-HR filed by Eagle Health Investments LP
Eagle Health Investments LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-07, with 23 holding rows worth $380,922,704.
- Accession
- 0001172661-25-004632
- Filer
- CIK 1842545
- Filed
- 2025-11-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 23 entries on the cover page, a total value of $380,922,704 stated on the cover page (in dollars after the unit check, H1), rows summing to $380,922,704 with VALUE read as dollars as filed, 13F file number 028-20556. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 77,430 | $57,109,271 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 271,600 | $39,113,116 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 203,664 | $32,783,794 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 182,590 | $31,953,250 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 322,261 | $30,605,127 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 162,800 | $22,853,864 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 697,000 | $20,965,760 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 366,812 | $19,866,538 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 284,100 | $17,750,568 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 270,950 | $14,823,675 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 363,300 | $13,529,292 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 259,300 | $13,468,042 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 308,434 | $11,008,009 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 23,686 | $10,800,816 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 226,400 | $10,749,472 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 246,230 | $9,883,672 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 988,772 | $8,325,460 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 935,450 | $5,360,129 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 103,100 | $2,500,175 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 81,800 | $2,454,000 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,390 | $1,963,340 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 46,300 | $1,682,079 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 240,500 | $1,373,255 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-25-004632 | this filing | 2025-11-07 | acceptance time not in the bulk data set |